Nasdaq Lays a Chicken-or-the-Egg Problem for Micro-Cap Issuers
2022 proved to be a difficult year for issuers seeking to raise capital. This is true for both private raises and public offerings. To give
2022 proved to be a difficult year for issuers seeking to raise capital. This is true for both private raises and public offerings. To give
For many employers, the end of the year brings many important tasks, deadlines, and legal updates. To assist you with your year-end projects and planning
On December 14, 2022, the Securities and Exchange Commission (the “SEC”) adopted final amendments to Rule 10b5-1 under the Securities Exchange Act of 1934, as
UPDATE: The December 27, 2022 deadline for group health plans to report certain prescription drug and medical spending information to the Centers for Medicare &
The Department of Labor (“DOL”) has finalized investment oversight and proxy voting regulations that will replace regulations on those topics issued by the Trump Administration.
On November 21, 2022, New York’s Cannabis Control Board (the “Board”), the approval and oversight body of the Office of Cannabis Management, conducted one of
On Thursday, November 10, 2022, a federal judge issued a preliminary injunction that will prevent the Office of Cannabis Management (“OCM”) from issuing Conditional Adult-Use
Tuesday was Election Day in New York and across the country. As it is an even-numbered year, all statewide offices, seats in the New York
The U.S. Department of Homeland Security (DHS) published a proposed rule that could eventually allow employers to remotely inspect I-9 documents. The proposed rule was
On October 26, 2022, the Securities and Exchange Commission (“SEC”) approved new rules requiring clawback provisions under Section 954 of the Dodd-Frank Act Wall Street